Previous studies have shown that Creatinine/Cystatin C (CCR) is a substitute indicator for sarcopenia in patients with gastric cancer, gastrointestinal stromal tumors, and esophageal cancer (42–44). This evidence concerns the gene CST3 and gastrointestinal stromal tumor.